Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Dbm-MMAF | 1810001-93-4 | 99.7% | 1082.95 g/mol | C49H74Br2N6O11 | 100 MG
SDP

Catalog No. 5000203394
Encompass_Preferred

DBM-MMAF is a drug-linker conjugate that couples the antitubulin payload monomethyl auristatin F (MMAF) to a DBM linker for antibody-drug conjugate (ADC) research. The product is supplied as a high-purity solid, soluble in DMSO, and intended for linker-payload synthesis and in vitro conjugation studies.

  • High purity (99.7%) solid for research use.
  • Molecular weight 1082.95 g/mol, formula C49H74Br2N6O11.
  • Soluble in DMSO at up to 200 mg/mL; ultrasonic assistance may be required.
  • Recommended storage: protect from light; in solvent store at -80°C (6 months) or -20°C (1 month).
  • Intended for ADC linker-payload synthesis and in vitro testing.

Catalog No. 50-002-03394 Supplier Medchemexpress LLC Supplier No. HY136287100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DBM-MMAF is a drug-linker conjugate that couples the antitubulin payload monomethyl auristatin F (MMAF) to a DBM linker for antibody-drug conjugate (ADC) research. The product is supplied as a high-purity solid, soluble in DMSO, and intended for linker-payload synthesis and in vitro conjugation studies.

  • High purity (99.7%) solid for research use.
  • Molecular weight 1082.95 g/mol, formula C49H74Br2N6O11.
  • Soluble in DMSO at up to 200 mg/mL; ultrasonic assistance may be required.
  • Recommended storage: protect from light; in solvent store at -80°C (6 months) or -20°C (1 month).
  • Intended for ADC linker-payload synthesis and in vitro testing.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.